More than 90% of cervical cancer cases are caused by human papillomavirus (HPV) infection. HPV is a common sexually ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in ...

Notably, 370 (83%) participants had squamous cell carcinoma ... outcomes for individuals with metastatic or recurrent cervical cancer. This evolution provides a pathway towards personalised treatment ...

Some estimates attribute as many as 20 percent of cancer cases to infectious agents, such as Epstein-Barr virus and hepatitis ...

Radiation therapy. This treatment uses high-energy waves to kill cancer cells. Many women under age 70 who have a lumpectomy get radiation, too. Doctors also might recommend this method if the ...

The National University Health System and National University of Singapore CAR T team of Dr Esther Chan (left), Dr Bernice Oh (centre) and Professor Allen Yeoh at the National University Hospital ...

Locally advanced cervical cancer accounts for around 40% of all cervical cancers. 1 Cisplatin-based chemoradiotherapy followed by brachytherapy has been the recommended treatment for over ... vaccines ...

Professor Ahmed Ahmed, study leader and director of the ovarian cancer cell laboratory at MRC Weatherall ... in a larger number of patients with melanoma post-surgery, to ensure it is an effective ...

Henrietta Lacks was an African American woman whose cancer cells ... with cervical cancer and died from the disease at Johns Hopkins Hospital in Baltimore, Maryland, in 1951. During her treatment ...

Oct 2 (Reuters) - Formula One will not hold a sprint race for rookie drivers in Abu Dhabi after the final grand prix of the season, the governing FIA said on Wednesday. The concept has been ...

Crown Castle's (NYSE:CCI) reported talks to sell its fiber business and small cell business for $8 billion to $10 billion is driving shares lower on Wednesday as the price is on the lower side of ...

Furthermore, these cells, called CAR-T cells, appear to be capable of targeting diseased cells in the tumor that do not carry this antigen, while sparing healthy cells. These results, published in the ...